| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T307 |
0-16 |
Sentence |
denotes |
• CytoResc Trial |
| T308 |
17-103 |
Sentence |
denotes |
• Cytokine storm in hyperinflammation and shock • Prospective, open-label, pilot study |
| T309 |
104-179 |
Sentence |
denotes |
• ‘CytoSorb’ polystyrene-based hemoadsorber to adsorb circulating cytokines |
| T310 |
180-203 |
Sentence |
denotes |
• N = 40–50 ‘CytoSorb’ |
| T311 |
204-229 |
Sentence |
denotes |
• N = 40–50 standard care |
| T312 |
230-384 |
Sentence |
denotes |
• Primary outcome is time to resolution of vasoplegic shock • ‘CytoSorb’ therapy administered via a shaldon catheter for 3–7 days (Stockmann et al., 2020) |
